Medicare begins covering weight-loss medications: who qualifies and how the new program will work
AI Summary
Medicare is rolling out a groundbreaking pilot program to cover GLP-1 medications for obesity, marking a significant shift in how it addresses weight management. Eligible beneficiaries can now access these treatments with a manageable monthly copay of $50, potentially reshaping the landscape for obesity care. This move highlights the growing recognition of obesity as a serious health condition that requires comprehensive treatment options, signaling a major step forward in preventative healthcare and management.
Original Source
Read the full article at English →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.